Objective. To determine the risk of myocardial infarction (MI) in patients with rheumatoid arthritis (RA) compared with that in patients with noninflammatory rheumatic disorders and to determine risk factors for MI in RA, the relationship between cardiovascular risk factors and corticosteroid use, and the relationship between RA treatment and MI.Methods. We conducted a cohort study of MI in 17,738 patients with RA and 3,001 patients with noninflammatory rheumatic disorders who were assessed at 6-month intervals between 1999 and July 2006. We evaluated treatment effect in a nested case-control study of RA participants who were matched by age, sex, study duration, and date of study entry.Results. The covariate-adjusted risk of first MI in RA versus that in noninflammatory rheumatic disorders was 1.9 (95% confidence interval 1.2-2.9) (P ؍ 0.005). In RA, MI was predicted by age, sex, education level, hypertension, smoking, exercise, prior MI, diabetes, a comorbidity index, use of low-dose aspirin and antilipemic agents, RA severity and treatment variables, and corticosteroid use. Except for obesity, predictors were of equal strength in RA and noninflammatory rheumatic disorders. The increased risk for MI in RA compared with that in noninflammatory rheumatic disorders lessened when corticosteroid users were excluded. Use of corticosteroids was associated with future development of diabetes and hypertension.Conclusion. MI in RA is associated with demographic and cardiovascular risk factors and corticosteroid use. Study data support the hypothesis that RA activity causes MI and that corticosteroids are primarily a marker of RA activity. However, corticosteroids increase the risk of diabetes and hypertension and contribute to the overall risk of MI.The risk of ischemic heart disease is substantially increased in rheumatoid arthritis (RA). Recent large epidemiologic studies have provided quantitative evidence of the association between RA and the risk of myocardial infarction (MI). The relative risk of MI was 2.0 (95% confidence interval [95% CI] 1.2-3.3) in the 2003 Women's Health Study (1), 1.9 (95% CI 1.7-2.1) in a 2006 report from a British Columbia population registry (2), 1.8 (1.2-2.4) in a community registry (3), and 1.5 (95% CI 1.2-1.8) in the UK-based General Practice Research Database (4). Older studies, including those using different study designs, have shown the risk to range from 1.1 to 5.2 (5). The mechanism by which RA exerts its effect is not clear, but it has been suggested to be independent of traditional cardiovascular risk factors (5,6).Baseline demographic and cardiovascular risk factors have been compared in patients who subsequently developed MI (7). However, no epidemiologic studies of MI risk are available that include a wide range